✦ LIBER ✦

Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium

✍ Scribed by Maria E Goossens, Frank Buntinx, Steven Joniau, Koen Ackaert, Filip Ameye, Ignace Billiet, Johan Braeckman, Alex Breugelmans, Jochen Darras, Kurt Dilen, Lieven Goeman, Eliane Kellen, Bertrand Tombal, Siska Van Bruwaene, Ben Van Cleyenbreuge, et al

Book ID: 119899056
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 183 KB
Volume: 12
Category: Article
ISSN: 1471-2490
DOI: 10.1186/1471-2490-12-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of intravesical thiotepa on t

The effect of intravesical thiotepa on tumour recurrence after endoscopic treatment of newly diagnosed superficial bladder cancer. A further report with long-term follow-up of a Medical Research Council randomized trial : Medical Research Council Working Party On Urological Cancer, Subgroup On Superficial Bladder Cancer

📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 512 KB

1051 Intracutaneous and intravesical imm

1051 Intracutaneous and intravesical immunotherapy with keyhole limpet hemocyanin versus intravesical mitomycin-C for prevention of recurrences in patients with non-muscle-invasive bladder cancer: Results from a prospective randomized phase III trial

✍ Lammers, R.J.M.; Witjes, W.P.J.; Janzing-Pastors, M.H.C.; Caris, C.T.M.; Witjes, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 130 KB

478 One immediate postoperative instilla

478 One immediate postoperative instillation of chemotherapy reduces the risk of recurrence in patients with stage TA T1 bladder cancer: A meta-analysis of the published results of randomized clinical trials

✍ R. Sylvester; W. Oosterlinck; Van der Meijden 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 207 KB

1771 TREATMENT WITH INTRACUTANEOUS AND I

1771 TREATMENT WITH INTRACUTANEOUS AND INTRAVESICAL KEYHOLE LIMPET HEMOCYANIN IS INFERIOR TO INTRAVESICAL MITOMYCIN-C FOR PREVENTION OF RECURRENCES IN PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER CANCER: RESULTS FROM A PROSPECTIVE RANDOMIZED PHASE III TRIAL

✍ Lammers, Rianne J.M.; Witjes, Wim P.J.; Janzing-Pastors, Maria H.C.; Caris, Chri 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 121 KB

875Reducing the risk of cancer recurrenc

875Reducing the risk of cancer recurrence and progression in patients with superficial bladder tumour with 5-aminolevulinic acid-induced fluore scence diagnosis. Results of a prospective randomized 5-year study

✍ D. Daniltchenko; C. Riedl; F. Koenig; M. Sachs; K. Daha; D. Schnorr; S. Loening 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 189 KB

The Impact of Intravesical Gemcitabine a

The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guérin Instillation Therapy on the Quality of Life in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Prospective, Randomized, Phase II Trial

✍ Gontero, Paolo; Oderda, Marco; Mehnert, Anja; Gurioli, Alberto; Marson, Francesc 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 618 KB